Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: A retrospective study

Sleep

Volumn 35, Issue 5, 2012, Pages 709-711

  Lecendreux, Michel ^a   Poli, Francesca ^b   Oudiette, Delphine ^c   Benazzouz, Fatima ^a,c   Donjacour, Claire E H M ^d   Franceschini, Christian ^b   Finotti, Elena ^b   Pizza, Fabio ^b   Bruni, Oliviero ^e   Plazzi, Giuseppe ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Childhood; GHB; Hypocretin; Narcolepsy with cataplexy; Sleepiness; Sodium oxybate; Treatment

Indexed keywords

CLOMIPRAMINE; DULOXETINE; IMIPRAMINE; MELATONIN; METHYLPHENIDATE; MODAFINIL; OXYBATE SODIUM; VENLAFAXINE;

ADD ON THERAPY; ARTICLE; AUDITORY HALLUCINATION; CATAPLEXY; CATATHRENIA; CHILD; CHILDHOOD DISEASE; CHILDHOOD NARCOLEPSY; CLINICAL ARTICLE; DIURNAL HALLUCINATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENURESIS; FEMALE; HAIR LOSS; HALLUCINATION; HUMAN; INSOMNIA; IRRITABILITY; MALE; NARCOLEPSY; NAUSEA; NIGHTMARE; OLFACTORY HALLUCINATION; PARASOMNIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SCHOOL CHILD; SEMI STRUCTURED INTERVIEW; SIDE EFFECT; SLEEP DISORDER; SLEEP DRUNKENNESS; SLEEP WALKING; SOMESTHETIC HALLUCINATION; STOMACH PAIN; TASTE DISORDER; WEIGHT REDUCTION;

ADOLESCENT; CHILD; DRUG TOLERANCE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; NARCOLEPSY; RETROSPECTIVE STUDIES; SODIUM OXYBATE; TREATMENT OUTCOME;

EID: 84860609389     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.1836     Document Type: Article

References (15)

1. nd ed.: diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
2. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511 (Pubitemid 46209316)
3. Han F, Lin L, Li J, et al. Presentations of primary hypersomnia in Chinese children. Sleep 2011;34:627-32.
4. Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep 2010;33:1457-64.
5. Guilleminault C, Pelayo R. Narcolepsy in prepubertal children. Ann Neurol 1998;43:135-42. (Pubitemid 28124662)
6. Nevsimalova S. Narcolepsy in childhood. Sleep Med Rev 2009;13:169-80.
7. Serra L, Montagna P, Mignot E, Lugaresi E, Plazzi G. Cataplexy features in childhood narcolepsy. Mov Disord 2008;23:858-65.
8. Plazzi G, Pizza F, Palaia V, et al. Complex movement disorders in childhood narcolepsy with cataplexy at disease onset. Brain 2011;134:3480-92.
9. Billiard M, Bassetti C, Dauvilliers Y, et al. EFNS guidelines on management of narcolepsy. Eur J Neurol 2006;13:1035-48. (Pubitemid 44434309)
10. Xyrem International Study Group. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep Med 2005;6:415-21.
11. Vienne J, Bettler B, Franken P, Tafti M. Differential effects of GABAB receptor subtypes, gamma-hydroxybutyric acid, and baclofen on EEG activity and sleep regulation. J Neurosci 2010;30:14194-204.
12. Murali H, Kotagal S. Off-label treatment of severe childhood narcolepsycataplexy with sodium oxybate. Sleep 2006;29:1025-9. (Pubitemid 44257379)
13. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990;44:45-60. (Pubitemid 20177198)
14. Lecendreux M, Maret S, Bassetti C, Mouren MC, Tafti M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res 2003;12:347-8. (Pubitemid 38010443)
15. Donjacour CE, Aziz NA, Roelfsema F, et al. The effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls. Am J Physiol Endocrinol Metab 2011;300:E1069-75. Erratum in: Am J Physiol Endocrinol Metab 2011;30:E426.